Durum Gida Sanyi Ve Ticaret A.S. v. United States
Opinion
This action involves the final determination of the U.S. Department of Commerce
*1369
("Commerce") rescinding the new shipper review ("NSR") of Plaintiff Durum Gida Sanyi Ve Ticaret A.S ("Plaintiff" or "Durum") for the period of July 1, 2014 to June 30, 2015.
See
Certain Pasta from Turkey
,
I. Standard of Review
The court sustains Commerce's "determinations, findings, or conclusions" unless they are "unsupported by substantial evidence on the record, or otherwise not in accordance with law." 19 U.S.C. § 1516a(b)(1)(B)(i). More specifically, when reviewing agency determinations, findings, or conclusions for substantial evidence, the court assesses whether the agency action is reasonable given the record as a whole.
Nippon Steel Corp. v. United States
,
II. Discussion
Durum is a Turkish pasta producer who sells "certain non-egg dry pasta in packages of five pounds (2.27 kilograms) or less" that is subject to Commerce's antidumping duty order covering certain pasta from Turkey.
See
Pl.'s Br. at 2 (citing
Notice of Antidumping Duty Order and Amended Final Determinations of Sales at Less Than Fair Value: Certain Pasta from Turkey
,
Commerce's regulations establish the procedures that govern new shipper reviews. Pursuant to these regulations, an exporter or producer seeking an NSR must include in its initial request documentation establishing, among other things, the date on which subject merchandise of the exporter or producer making the request was first entered, or withdrawn from warehouse, for consumption, or, if the exporter or producer cannot establish the date of first entry, the date on which the exporter or producer first shipped the subject merchandise for export to the United States.
Commerce rescinded Durum's NSR after finding that Durum had not filed its request within one year of its first United States sale. Specifically, Commerce found that: (1) Durum had invoiced a sale of subject merchandise to a U.S.-based consignee in November 2011; (2) Durum knew that, at minimum, this non-POR sale was destined for the United States; (3) Durum had reported the non-POR sale to the U.S. Government as a consumption entry; and (4) record evidence did not substantiate Durum's claim of an agreement with its U.S.-based consignee, that Durum's shipments, including the non-POR sale, would not enter U.S. customs territory.
See
Confidential Decision Memorandum
at 8-10. Because Durum did not request an NSR within one year of the non-POR sale, Commerce determined that Durum had failed to comply with
Durum does not challenge Commerce's methodology, but instead argues
*1371
that Commerce wrongly considered Durum as the exporter of the non-POR sale. Durum contends that because Durum did not know that the non-POR sale would enter U.S. customs territory, it was not the "price discriminator" under Commerce's "knowledge test" and thus was not the exporter of the non-POR sale under Commerce's regulations.
See
Pl.'s Br. at 4-7. In addressing Durum's arguments, Commerce accepted that some form of the "knowledge test" could aid it in determining whether Durum was the exporter for the non-POR sale.
See
Confidential Decision Memorandum
at 8. While Commerce traditionally uses the "knowledge test" to determine whether certain sales are attributable to a respondent for calculating that respondent's margins in antidumping duty proceedings, Commerce here looked to that test for guidance in evaluating Durum's claim that it was not the exporter of the non-POR sale for the purposes of
As to Durum's knowledge of the ultimate destination of the non-POR sale, Durum relied heavily on the declaration of its Assistant General Manager Derya Akyel ("Akyel Declaration"). Commerce found that the Akyel Declaration failed to provide the support for Durum's purported lack of knowledge of the destination of that sale. Specifically, Commerce found that the declaration lacked (1) credibility in that Ms. Akyel did not appear to have been personally involved with the non-POR sale and her name did not appear on any of the sales documentation on the record for that sale, (2) contemporaneity in that the declaration was made several years after the non-POR sale, and (3) any accompanying supporting documentation contemporaneous with or prior to the non-POR sale. See Confidential Decision Memorandum at 10.
Before the court, Plaintiff challenges Commerce's determination that Durum had knowledge of the nature and ultimate destination of the non-POR sale (i.e., that the pasta shipment would enter U.S. customs territory). Pl.'s Br. at 18-25. Specifically, Durum contends that Commerce improperly discounted the Akyel Declaration, maintaining that the declaration is "the only record evidence that specifically addresses Durum's knowledge of where the sales were ultimately destined."
The court disagrees. Commerce reasonably explained that it had concerns regarding the credibility and contemporaneity of the Akyel Declaration.
See
Confidential Decision Memorandum
at 10. Commerce explained that "it is the Department's
*1372
practice to attach more weight to documentary evidence than to statements such as declarations," and that Durum failed to provide contemporaneous documentary evidence that would support Ms. Akyel's assertions with respect to Durum's knowledge at the time of the non-POR sale.
Moreover, despite Durum's contentions that the signatures on the documents in the July 19th Memo were "easily-readible," the record supports Commerce's finding to the contrary. Any appearance of Ms. Akyel's signature on those documents is "faint" and arguably illegible. See Confidential Joint Appendix, ECF No. 38, Tab 3, CD 144-47 (July 19th Memo). Durum has failed to demonstrate that the record leads to one and only one conclusion, namely that Ms. Akyel signed and was personally connected to the non-POR sale and its documentation. Accordingly, the court holds that Commerce's consideration of the Akyel Declaration and the entry documents in the July 19th Memo was reasonable.
Durum also contends that Commerce disregarded other information in the record indicating that the non-POR sale was intended for consumption on cruise ships via bonded transfer through a Foreign Trade Zone and that Durum did not know that its product would enter U.S. customs territory. Pl.'s Br. at 22-23. Specifically, Durum argues that Commerce overlooked "obvious" information in the record when it suggested that the destination port for the non-POR sale was either Port A or Port B.
6
Commerce explained that it assigned significant evidentiary weight to the entry documents from CBP and as well as an FDA entry notice associated with the non-POR sale, and found that "Durum made a shipment of subject merchandise that entered the United States on [ [ ] ], and that it knew the shipment was destined for a customer located in the United States." Id. at 10. The record additionally confirmed that the non-POR sale entered the United States as a consumption entry. Id.
Durum contends that Commerce failed to consider that portion of the record that fairly detracts from Commerce's finding that Durum knew the non-POR sale would enter U.S. customs territory. See Pl.'s Br. at 23-25. Specifically, Durum argues that its communications and pattern of sales with the parties involved in the non-POR
*1373 sale support Durum's position that sales with these parties were intended to avoid U.S. customs territory by entering a Foreign Trade Zone ("FTZ") for subsequent loading onto cruise ships. Id. at 10, 23-25. Even though the non-POR sale was processed and entered as a consumption entry, Durum nevertheless suggests that the court should recognize the consumption entry as a "mistake" given that subsequent sales to the same parties did not appear in CBP data searches. Id. at 24. The court declines Durum's invitation. Durum's arguments all depend on documentation that Commerce found was not contemporaneous with the non-POR sale. In fact, all of Durum's documentation and pattern of trade evidence post-dates the non-POR sale at issue. See Confidential Decision Memorandum at 9-10. While Durum may have speculated that the non-POR sale would not enter U.S. customs territory, Durum's proffered information fails to establish that Durum "had no knowledge that the [non-POR sale] would enter U.S. customs territory." Id.
Durum's position is weakened by a document from Durum's own evidentiary submissions that directly support Commerce's finding that Durum knew its non-POR sale would enter the U.S. as a "consumption entry." See Confidential Joint Appendix, ECF No. 38, Tab 6, Att. 2, CD 152-153 (Durum's administrative rebuttal brief and attachment of an FDA Prior Notice Entry Confirmation ("FDA Notice") ). Specifically, Durum placed on the record an FDA Prior Notice Entry Confirmation, submitted to the FDA in connection with the non-POR sale, which directs the holder to "print this Web Entry Summary Confirmation and present it to U.S. Customs and Border Protection (CBP) or the Food and Drug Administration (FDA) at the Port of Arrival." Id. The FDA Notice identifies the "Submitter" as Durum and identifies the "Entry Type" as "Consumption." Id. Accordingly, the record provides support for Commerce's conclusion that Durum knew the non-POR sale would enter U.S. customs territory because Durum affirmatively represented to the U.S. Government that the non-POR sale was a consumption entry. See Confidential Decision Memorandum at 9 & n.27 (citing the FDA Notice and determining that "record facts support a conclusion that Durum had knowledge of the U.S. destination of its [non-POR] sale and being the appropriate party to be examined in this NSR"). 7
Durum next contends that the Government in its response brief improperly relies on the FDA Notice, arguing that the Government is attempting to use the FDA Notice in a post-hoc fashion to indicate Durum's state of mind, despite Commerce only having cited the FDA Notice for the purpose of establishing that the non-POR sale entered the United States as a "consumption entry." Pl.'s Reply at 6-7. Durum's argument fails as the court concludes that Commerce's reliance on the FDA Notice as state of mind evidence is reasonable based on the fact that the FDA Notice was cited in the
Confidential Decision Memorandum
as providing facts that "support a conclusion that Durum had knowledge of the U.S. destination of its
*1374
[non-POR] sale and being the appropriate party to be examined in this NSR."
Confidential Decision Memorandum
at 9;
see also
NMB Singapore Ltd. v. United States
,
Perhaps recognizing the weakness of its argument before the court that Defendant's reliance on the FDA Notice constitutes an impermissible post-hoc rationalization, Durum argues in the alternative that the information in the FDA Notice only indicates the knowledge of its agent
8
, who transmitted the information in the FDA Notice to the FDA on behalf of Durum. Pl.'s Reply at 7-8. Durum highlights that in a handwritten form submitted by Durum to its agent, Durum did not provide any information describing the entry type for the non-POR sale.
Durum asserts that despite the information in the CBP entry documents and the FDA Notice supporting Commerce's knowledge finding, Commerce nevertheless lacked adequate record information to support a finding that Durum knew of the destination of the non-POR sale under the "knowledge test."
See
Pl.'s Br. at 19-22. In particular, Durum relies on
Hiep Thanh Seafood Joint Stock Co. v. United States
, 35 CIT ----,
In
Hiep Thanh II
, the court was not presented with an untimely request for a new shipper review. Rather, in that case, Commerce analyzed whether certain sales should have been included in the respondent's margin calculation as part of the respondent's U.S. sales database.
Hiep Thanh II
, 35 CIT at ----,
In this matter, unlike in
Hiep Thanh II
, Durum knew that its customer was a U.S. company.
See
Confidential Decision Memorandum
at 9-10. Furthermore, in
Hiep Thanh II
, commercial invoices and packing lists on that record "name[d] the Mexican customer and specif[ied] the ultimate destination of the product as 'Mexico via [a port within the United States].' "
Hiep Thanh II
, 35 CIT at ----,
Finally, Durum's reliance on
Hiep Thanh II
ignores the subsequent history of that case in which the court sustained Commerce's determination, noting that the respondent had "shipped merchandise covered by an antidumping duty order to a U.S. port ... without any qualification or limitation against U.S. entry."
See
Hiep Thanh Seafood Joint Stock v. United States
, 36 CIT ----, ----,
Ultimately, the court observes that Durum's position-that it understood the non-POR sale would travel through an FTZ before delivery to cruise ships technically outside of U.S. customs territory-is
one reasonable conclusion
that could be drawn from this record. However, for Durum to prevail the record must lead a reasonable mind to draw one and only one conclusion: Durum had no knowledge that the non-POR sale would enter U.S. customs territory. That conclusion, in turn, depends upon inferences to be drawn from the available record evidence-inferences that must compete with direct record evidence and other inferences (having perhaps an equal or better claim) that Durum knew at the time of the non-POR sale that the sale would enter the U.S. as a consumption entry.
See, e.g.
,
Hiep Thanh III
, 36 CIT at ----,
*1376
Mitsubishi Heavy Indus. Ltd. v. United States
,
III. Conclusion
Based on the foregoing, the court sustains Commerce's Rescission . Judgment will enter accordingly.
"CD ___" refers to a document contained in the confidential administrative record.
All citations to the agency record and the parties' briefs are to their confidential versions.
Further citations to the Tariff Act of 1930, as amended, are to the relevant provisions of Title 19 of the U.S. Code, 2012 edition.
Durum's U.S.-based consignee is [ [ ] ].
Durum invoiced a sale of subject merchandise in November 2011, which entered the United States on [ [ ] ]. See Confidential Decision Memorandum at 2.
Port A is [ [ ] ], and Port B is [ [ ] ].
Durum's counsel suggested at oral argument that there was no evidence that Durum ever actually submitted this FDA Notice to the Government. See Oral Argument at 27:20-29:22, ECF No. 45 (Apr. 5, 2018). This argument fails given that the totality of the document indicates on its face that it was submitted to the FDA in December 2011, lists Durum as the "Submitter," and identifies the entry type as "Consumption." See FDA Notice; Oral Arg. at 36:55-38:00.
Durum's agent is [ [ ] ].
Case-law data current through December 31, 2025. Source: CourtListener bulk data.